ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

The Avastin Story In A Nutshell: A Timeline

May 27, 2011

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993

Also NCI prostate SPOREs plan biospecimen bank.

December 10, 2004